Faster, more accurate, and more comfortable tests. 7
Technology your patients will actually want to use
Monitor accurately without compromising patient comfort and their daily routine.
Wireless and water-resistant
Online transmission
Artificial Intelligence analysis
Loved by doctors and highly rated by patients.
Average rating of 4.7/5 for user-friendly ⁸ and reliability.
Set up, create tests, and manage continuous monitoring.
Requestor App
Continuous monitoring, more accurate diagnoses.
Study confirms: uninterrupted recording of heart rhythm increases arrhythmia detection.1, 9
Diagnoses enhanced by Artificial Intelligence.
Identifies anomalies imperceptible to the human eye.
Real-time capture and transmission via Bluetooth
Fast analysis of large volumes of data 10
Identification of arrhythmia patterns 10
99% accuracy in identifying Atrial Fibrillation (AF) 7
ZERO initial investment
Technical support and training included in the subscription
Device replacement if necessary
Devices and charger at no additional cost
Payment per test performed
Over 2,000 cardiologists prescribe QuoreOne in Brazil.
Why are cardiologists switching to QuoreOne?
Zero investment: subscription model and payment per test.
Reduction in average diagnosis time from 45 to 4 days.
Comprehensive technical support: installation, training, maintenance, and updates.
Up to 1.6x higher diagnosis yield for severe arrhythmias with long-term monitoring. 4
Advanced AI analysis that increases Atrial Fibrillation detection. 7
Intuitive digital platform for test management and real-time data access.
Expand your services: perform continuous cardiac monitoring from 24 hours up to 7 days.
Fully wireless and online: no wires, memory cards, or batteries to replace.
Greater patient adherence to the test, with a significant reduction in repetitions.
References
1. Worldometer, Current World Population, disponível em: [https://www.worldometers.info/world-population/], acesso em 25Abr2025
2. Karamitanha F., et al, Difference Between Various Countries in Mortality and Incidence Rate of the Atrial Fibrillation Based on Human Development Index in Worldwide: Data From Global Burden of Disease 2010-2019, Current Problems in Cardiology Volume 48, Issue 1, January 2023, 101438
3. Van Gelder I. C, et al, 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal (2024) 00, 1-101, https://doi.org/10.1093/eurheartj/ehae176 and Risks, 1990-2022100000.
4.Known S., et al, Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study, J Med Internet Res. 2022 May; 24(5): e37970. Published online 2022 May 9. doi:
10.2196/37970: 10.2196/37970.
5. Kim J. Y., et al, The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring, Journal of Arrhthmia, Received: 3 January 2023 | Revised: 13 April 2023 | Accepted: 20 April 2023, DOI: 10.1002/joa3.12865.
6. Cadastro Nacional de Estabelecimentos de Saúde (CNES), Consulta Estabelecimentos, Nome com “COR” ou “CARDIO”, mediana dos estabelecimentos, disponível em: [https://cnes.datasus.gov.br/], acesso em 02Maio2025.
7. Hospital Israelita Albert Einsteim, A Comparative study of an innovative 3-lead wireless water resistant Holter system and a conventional Holter system, disponível em: [https://clinicaltrials.gov/study/NCT04723355?term=Quoretech&rank=1]; acesso em
8. Data on File, Quoretech Jul/21 onde 44,4%
9. Yenikomshian M., et al, Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review, Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.
10. Leclercq C., et al, Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table, EP Europace, Volume 24, Issue 9, September 2022, Pages 1372-1383, https://doi.org/10.1093/europace/euac05
11. ROL_ANS, disponível em: [https://www.ans.gov.br/ROL-web/pages/cobertura.xhtml], acesso em: 25Abr2025
12. SOBRAC, A vida de um portador de arrimtia cardíaca, disponível em: [https://sobrac.org/publico-
geral/sdrfvesfvs/], acesso em 25Abr2025
13. ANS, Procedimentos 2023, disponível em: [https://app.powerbi.com/view?r=eyJrIjoiNzIxNz|4MjItZTEwNyO0NmQ2LTk3ZTktZDNjYjA5Zjk2MTIOliwid
Cl6ljlkYmEOODBjLTRmYTctNDJmNC1iYmEzLTBmYjEzNzVmYmU1ZiJ9], acesso em 25Abr2025
14. DATASUS, PRODUÇÃO AMBULATORIAL DO SUS – BRASIL – POR LOCAL DE ATENDIMENTO, HOLTER, disponível em: [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qabr.def], acesso em 25Abr2025
